Wang et al. found that miR-9-5p inhibited pancreatic cancer cell proliferation, invasion, glutamine metabolism and redox homeostasis by downregulating GOT1 expression, suggesting that miR-9-5p may serve as a prognostic or therapeutic target in pancreatic cancer [22]. This evidence concerns the gene GOT1 and familial pancreatic carcinoma.